Using a two-pronged attack, first CLP-induced sepsis and then fungal sepsis using C. albicans, researchers created a model of sepsis and found that the novel PD-L1 blocking peptide, compound 8, decreases mortality by half (170). The gene discussed is CD274; the disease is Sepsis.